Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-354-6 | CAS number: 106-02-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- From 2001-07-23 to 2001-09-17
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study performed according to OECD test guideline No. 476 and in compliance with GLP. The study was fully reliable (Klimisch score = 1), however the reliability score was lowered to 2 which is the maximum score for read-across. The supporting substance is considered adequate for read-across purpose (see Iuclid section 13 for justification).
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- UK GLP (inspection date: 2000-02-28)
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- A mixture of: (E)-oxacyclohexadec-12-en-2-one; (E)-oxacyclohexadec-13-en-2-one; a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one
- EC Number:
- 422-320-3
- EC Name:
- A mixture of: (E)-oxacyclohexadec-12-en-2-one; (E)-oxacyclohexadec-13-en-2-one; a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one
- IUPAC Name:
- 422-320-3
- Test material form:
- other: viscous liquid
- Details on test material:
- - Name of test material (as cited in study report): ST 12 C 00
- Physical state: colourless viscous liquid
- Storage condition of test material: room temperature under nitrogen, in the dark
Constituent 1
Method
- Target gene:
- Thymidine kinase
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- - Type and identity of media: L5178Y TK+/- 3.7.2c mouse lymphoma cell line obtained from Dr J Cole of the MRC Cell Mutation Unit at the University of Sussex, Brighton, UK.
- Properly maintained: yes, stored in liquid nitrogen at -196°C.
- Periodically checked for Mycoplasma contamination: no data
- Periodically checked for karyotype stability: no data
- Periodically "cleansed" against high spontaneous background: yes, by culturing in THMG medium for 24 hours. For the following 24 hours the cells were cultured in THG medium (i.e. THMG without Methotrexate). - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- PB/betaNF S9: S9-mix
- Test concentrations with justification for top dose:
- Preliminary toxicity test using 36.88 to 2360 µg/mL
Exp 1: without S9-mix, six doses levels 2.5 to 40 µg/mL
Exp 1: with S9-mix, six doses levels 5 to 80 µg/mL
Exp 2: without S9-mix, six doses levels 5 to 50 picog/mL
Exp 2: with S9-mix, six doses levels 10 to 70 picog/mL - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: no data
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 800 µg/mL in Exp 1 and 150 µg/mL in Exp 2
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- without metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- at 2.5 µg/mL
- Positive control substance:
- cyclophosphamide
- Remarks:
- with metabolic activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Preincubation period: no
- Exposure duration: 3 hours in Experiment 1, 3 hours with metabolic activation cultures and 24 hours without metabolic activation in Experiment 2
- Expression time (cells in growth medium): two days
- Selection time (if incubation with a selection agent): 10 to 14 days
- Fixation time (start of exposure up to fixation or harvest of cells): NA
SELECTION AGENT (mutation assays): Trifluorothymidine
NUMBER OF REPLICATIONS: 2, both with and without metabolic activation
NUMBER OF CELLS EVALUATED: the cells were counted and processed to give 1* 10exp6 cells/mL in 10 ml aliquots in R10 medium
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - After the preliminary toxicity test, the cultures were incubated and sub-cultured after 24 hours by counting and diluting to 2 x 10EXP5 cells/mL. After a further 24 hours the cultures were counted and then discarded. The cell counts were then used to calculate suspension growth values (SG). The SG values were then adjusted to account for immediate post treatment toxicity, and a comparison of each treatment SG value to the concurrent vehicle control performed to give a % Relative Suspension Growth Value (%RSG).
OTHER
- Other: Determination Plating Efficiency: Since the distribution of colony-forming units over the wells is described by the Poisson distribution, the plating efficiency (P.E.) was calculated using the zero term of the Poisson distribution [P(O)] method.
- Other: Determination of Calculation of Mutation Frequency - M.F. per survivor = [(-In P(O) selective medium)/cells per well in selective medium)]/surviving fraction in non-selective medium. The experimental data was analysed using a dedicated computer program which follows the statistical guidelines recommended by the UKEMS. - Evaluation criteria:
- For a test material to give a 'significant' result then 2 or more of the following criteria should be met:
i) A greater than three-fold increase in the mutant frequency per survivor over the negative control value.
ii) A dose-related increase in the mutant frequency per survivor.
iii) An increase in the absolute number of mutants.
A test material may be reported as equivocal if only one of the above criteria is met. Small significant increases designated by the UKEMS statistical package will be reviewed using the above criteria, and may be disregarded at the Study Director's discretion. - Statistics:
- Statistics will be found in the attached tables.
Results and discussion
Test results
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no change in pH at maximum dose level
- Effects of osmolality: 10 mM maximum dose level used in preliminary toxicity test
- Precipitation: not seen
RANGE-FINDING/SCREENING STUDIES:
A preliminary toxicity test was performed on cell cultures at 5 x 10EXP5 cells/ml, using a 3-hour exposure time both with and without metabolic activation (S9), and at 1.5 x 10EXP5 cells/ml using a continuous 24-hour exposure without S9. The dose range used in the preliminary toxicity test was initially 36.88 to 2360 ug/ml. However, the test material proved to be very toxic and the preliminary toxicity test was repeated using the. dose range 0.625, 1.25, 2.5, 5, 10, 20 and 40 ug/ml in the 3-hour exposure group, both with and without S9, and 1.25, 2.5, 5.0, 10, 20, 30 and 40 ug/ml in the 24-hour exposure without S9. Following the exposure period the cells were washed twice with R10, resuspended in R20 medium, counted using a coulter counter and then serially diluted to 10 cells/ml.
COMPARISON WITH HISTORICAL CONTROL DATA: Vehicle control mutation frequencies were within historical ranges.
ADDITIONAL INFORMATION ON CYTOTOXICITY: - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
(All the tables mentioned in this section will be found as attachment)
Preliminary Toxicity Test The dose range of the test material used in the preliminary toxicity test was initially 36.88 to 2360 µg/mL. However, due to excessive toxicity it was repeated using the dose range of 0.625 to 40 µg/mL. The results of the Day 0 Relative Suspension Growth (RSG) were as follows:
Dose (ug/ml) | % RSG (-S9) 3 -hour Exposure |
% RSG (+S9) 3 -hour Exposure |
% RSG (-S9) 24-hour exposure |
|
0 | 100 | 100 | 100 | |
(1.25)a | 0.625 | 101 | 113 | 91 |
(2.5)a | 1.25 | 118 | 123 | 96 |
(5)a | 2.5 | 119 | 108 | 98 |
(10)a | 5 | 114 | 107 | 98 |
(20)a | 10 | 117 | 115 | 90 |
(30)a | 20 | 102 | 112 | 93 |
(40)a | 40 | 3 | 101 | 55 |
a=24 -h exposure dose levels
It can be seen, in both of the groups in the absence of metabolic activation (S9), that there was a marked reduction in the %RSG value of cells treated with the test material at the maximum dose level when compared to the concurrent vehicle controls indicating a steep toxicity curve. In the presence of metabolic activation, there was no reduction in %RSG. However in the initial preliminary toxicity test (data not shown) there was no survival at dose levels greater than 36.88 µg/mL. No precipitate of test material was observed in any dose level up to 40 µg/mL. In the mutagenicity test the maximum dose was limited by the toxicity of the test material.
Mutagenicity Test
Experiment 1 The results of the Day 0 and Day 2 microtitre plate counts and their analysis are presented in Tables 1 to 6. The test material showed some evidence of toxicity (reduced %RSG values) at the upper two dose levels only. The toxicity dose response curve was observed to be extremely steep. The toxicity observed at 80 µg/mL in the presence of metabolic activation exceeded the upper acceptable limit of 90%, therefore, the dose was excluded from the statistical analysis. Toxicity was seen with both positive control substances (Table 2 and Table 5). Neither of the vehicle control mutant frequencies were outside the range of 25 to 150 x 10EXP-6 viable cells that is acceptable for L5178Y cells at Safepharm Laboratories. Both of the positive controls produced marked increases in the mutant frequency per viable cell indicating that the test system was operating satisfactorily and that the metabolic activation system was functional (Tables 2 and 5). The test material did not induce any significant or dose related (linear-trend) increases in the mutant frequency x 10-6 per viable cell in either the presence or absence of metabolic activation (Tables 2 and 5). No precipitate of test material was observed at any dose level. The numbers of small and large colonies and their analysis are presented in Tables 3 and 6.
Experiment 2 The results of the Day 0 and Day 2 microtitre plate counts and their analysis are presented in Tables 7 to 12. The 24-hour continuous exposure without metabolic activation (S9) treatment, demonstrated that the extended time point had no marked effect on the toxicity of the test material. As was seen in Experiment 1 there was evidence of a steep dose-related reduction in the %Relative Suspension Growth values for cultures dosed with the test material in both the absence and presence of metabolic activation. There was no evidence of a reduction in Day 2 (%V) viability, however, there was some evidence of a reduction in relative total growth (RTG), indicating that some residual toxicity had occurred, in both exposure groups. The toxicity observed in the presence of metabolic activation was within the optimum maximum range of 80 to 90%. In the absence of metabolic activation the maximum toxicity observed was just below the optimum range of 80 to 90%. It was considered that the test material had been adequately tested because of the extremely steep dose-response curve. Both positive controls produced reductions in both the %RSG value and Day 2 (%V) viabilities and RTG values (Tables 8 and 11). Neither of the vehicle control mutant frequencies were outside the acceptable range of 25 to 150 x 10EXP-6 viable cells. Both of the positive controls produced marked increases in the mutant frequency per viable cell indicating that the test system was operating satisfactorily and that the metabolic activation system was functional (Tables 8 and 11). The test material did not induce any statistically significant or dose-related increases in the mutant frequency per viable cell in either the absence or presence of metabolic activation (Table 8 and 11). No precipitate of test material was observed at any dose level tested. The numbers of small and large colonies and their analysis are presented in Tables 9 and 12.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation
The test material did not induce any toxicologically significant increases in the mutant frequency at the TK +/- locus in L5178Y cells and was therefore considered to be non-mutagenic under the conditions of the test. - Executive summary:
In a mammalian cell gene mutation assay performed according to the OECD test guideline No. 476 and in compliance with GLP, L5178Y mouse lymphoma cells were exposed to the test material diluted in DMSO at 6 dose levels, in duplicate in the presence and absence of metabolic activation (S9-mix). The entire experiment was repeated to confirm the result of the first experiment. Three-hour exposures were used both with and without activation (S9) in Experiment 1. In Experiment 2 the exposure time without activation was increased to 24 hours. The dose range of test material, plated out for expression of mutant colonies, was selected on the results of a preliminary toxicity test and was 2.5 to 40 µg/mL in the absence of S9 and 5 to 80 µg/mL in the presence of S9 for the first experiment. For the second experiment the dose range was 10 to 70 µg/mL with activation and 5 to 50 µg/mL without activation. The maximum dose level used was limited by the presence of precipitate. A precipitate of the test material was not observed at any dose level used in the main study.
The vehicle (solvent) controls gave acceptable levels of mutant frequencies for the L5178Y cell line at the TK +/- locus.
The positive control treatments, both in the absence and presence of metabolic activation, induced marked increases in the mutant frequency indicating the satisfactory performance of the test and of the activity of the metabolising system.
The test material did not induce any statistically significant or dose-related increases in the mutant frequency at any dose level, either with or without metabolic activation, in either the first or the second experiment.
Under the test conditions, the test material is not classified according to the annex VI of the Regulation EC No. 1272/2008 (CLP) and of the Directive 67/548/EEC.
This study is considered as acceptable and satisfies the requirement for the mammalian cell gene mutation endpoint.
The supporting substance is considered adequate for read-across purpose (see Iuclid section 13 for justification).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.